1. Home
  2. NYXH vs JYNT Comparison

NYXH vs JYNT Comparison

Compare NYXH & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • JYNT
  • Stock Information
  • Founded
  • NYXH 2009
  • JYNT 2010
  • Country
  • NYXH Belgium
  • JYNT United States
  • Employees
  • NYXH N/A
  • JYNT N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • JYNT Multi-Sector Companies
  • Sector
  • NYXH Health Care
  • JYNT Miscellaneous
  • Exchange
  • NYXH Nasdaq
  • JYNT Nasdaq
  • Market Cap
  • NYXH 185.5M
  • JYNT 149.5M
  • IPO Year
  • NYXH 2021
  • JYNT 2014
  • Fundamental
  • Price
  • NYXH $6.48
  • JYNT $8.53
  • Analyst Decision
  • NYXH Strong Buy
  • JYNT Strong Buy
  • Analyst Count
  • NYXH 3
  • JYNT 3
  • Target Price
  • NYXH $15.00
  • JYNT $16.33
  • AVG Volume (30 Days)
  • NYXH 83.5K
  • JYNT 97.5K
  • Earning Date
  • NYXH 11-05-2025
  • JYNT 11-06-2025
  • Dividend Yield
  • NYXH N/A
  • JYNT N/A
  • EPS Growth
  • NYXH N/A
  • JYNT N/A
  • EPS
  • NYXH N/A
  • JYNT N/A
  • Revenue
  • NYXH $5,793,306.00
  • JYNT $53,449,713.00
  • Revenue This Year
  • NYXH $85.62
  • JYNT $7.70
  • Revenue Next Year
  • NYXH $320.09
  • JYNT $10.24
  • P/E Ratio
  • NYXH N/A
  • JYNT N/A
  • Revenue Growth
  • NYXH 2.94
  • JYNT 277.36
  • 52 Week Low
  • NYXH $4.35
  • JYNT $8.64
  • 52 Week High
  • NYXH $11.87
  • JYNT $13.47
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 65.15
  • JYNT 21.20
  • Support Level
  • NYXH $4.36
  • JYNT $9.06
  • Resistance Level
  • NYXH $6.75
  • JYNT $9.93
  • Average True Range (ATR)
  • NYXH 0.32
  • JYNT 0.32
  • MACD
  • NYXH 0.27
  • JYNT -0.11
  • Stochastic Oscillator
  • NYXH 89.12
  • JYNT 0.79

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

Share on Social Networks: